The use of platelets as a clinical tool in oncology: opportunities and challenges
Cancer Letters · 2024-12 · 607 · 217044
DOI: 10.1016/j.canlet.2024.217044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2024-12. Verfasst von Sara Bravaccini und 8 weiteren Autor:innen. Beteiligte Einrichtung: IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", via P. Maroncelli 40, 47014, Meldola, Italy. Electronic address: sara.bravac…. Hauptthemen laut MEDLINE: Blood Platelets, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 214 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Platelets are small circulating anucleated cells mainly involved in thrombosis and hemostasis processes. Moreover, platelets play an active role in tumorigenesis and cancer progression, stimulating angiogenesis and vascular remodelling, and protecting circulating cancer cells from shear forces and immune surveillance. Several reports indicate that platelet number in the blood circulation of cancer patients is associated with prognosis and response to treatment. However, the mechanisms of platelets "education" by cancer cells and the crosstalk between platelets and tumor are still unclear, and the role of "tumor educated platelets" (TEPs) is achieving growing interest in cancer research. TEPs are a biological source of cancer-derived biomarkers, especially RNAs that are protected by platelets membrane from circulating RNases, and could serve as a non-invasive tool for tumor detection, molecular profiling and evolution during therapy in clinical practice. Moreover, short platelet lifespan offers the possibility to get a snapshot assessment of cancer molecular profile, providing a real-time tool. We review and discuss the potential and the clinical utility, in terms of cancer diagnosis and monitoring, of platelet count together with other morphological parameters and of the more recent and innovative TEP profiling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", via P. Maroncelli 40, 47014, Meldola, Italy. Electronic address: sara.bravaccini@irst.emr.it.
- Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV-IRCCS, 35128, Padua, Italy. Electronic address: elisa.boldrin@iov.veneto.it.
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", via P. Maroncelli 40, 47014, Meldola, Italy. Electronic address: giorgia.gurioli@irst.emr.it.
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", via P. Maroncelli 40, 47014, Meldola, Italy. Electronic address: gianluca.tedaldi@irst.emr.it.
- Immunology and Molecular Oncology Diagnostics Unit, Veneto Institute of Oncology IOV-IRCCS, 35128, Padua, Italy. Electronic address: mariaassunta.piano@iov.veneto.it.
- IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori", via P. Maroncelli 40, 47014, Meldola, Italy. Electronic address: matteo.canale@irst.emr.it.
Zitieren
APA
Bravaccini, S., Boldrin, E., Gurioli, G., Tedaldi, G., Piano, M. A., Canale, M., Curtarello, M., Ulivi, P., & Pilati, P. (2024). The use of platelets as a clinical tool in oncology: opportunities and challenges. Cancer Letters, 607, 217044. https://doi.org/10.1016/j.canlet.2024.217044
Vancouver
Bravaccini S, Boldrin E, Gurioli G, Tedaldi G, Piano MA, Canale M, et al. The use of platelets as a clinical tool in oncology: opportunities and challenges. Cancer Letters. 2024;607:217044. doi:10.1016/j.canlet.2024.217044
BibTeX
@article{Bravaccini2024,
author = {Bravaccini, Sara and Boldrin, Elisa and Gurioli, Giorgia and Tedaldi, Gianluca and Piano, Maria Assunta and Canale, Matteo and Curtarello, Matteo and Ulivi, Paola and Pilati, Pierluigi},
title = {The use of platelets as a clinical tool in oncology: opportunities and challenges},
journal = {Cancer Letters},
year = {2024},
volume = {607},
pages = {217044},
doi = {10.1016/j.canlet.2024.217044}
}
EUVIMED